Assoc. Prof. Resul Kahraman, M.D.

2023 – Present
Group Florence Nightingale Hospitals
Director of Gastroenterology

2020
University of Health Sciences
Gastroenterology

2012
Turkish Ministry of Health
Gastroenterology

2009
University of Health Sciences
Gastroenterology

2009
Ministry of Health-Turkish Ministry of Health
Internal Medicine

2003
Istanbul University
Doctor (Internal Medicine)

• Pancreatic Lesions

• Pancreatic Tumor Biopsies

• Pancreatic Tumor RF Ablation Treatments

• Endoscopic Methods in Reflux Treatment

• Treatment of achalasia with POEM

• Stent Applications in Gastrointestinal Stenosis

• Endoscopy

• Interventional Gastroenterology

 

2012
Health Sciences University Immunology PhD Prg.

2012
SBU. Ümraniye EAH Gastroenterology Clinic

2010
Cleveland Clinic
Gastroenterology Observer

2008
Istanbul Faculty of Medicine
Internal Medicine

2002
Istanbul Faculty of Medicine

• Ozdil K, Calhan T, Sahin A, Kahraman R et al. Levofloxacin Based Sequential and Triple Therapy Compared with Standart Plus Probiotic Combination for Helicobacter Pylori Eradication. ‘’National Scholar Award’’ 2011 UEGW Stockholm.
• Resul Kahraman, Sinem Bireller, Turan Çalhan, Abdurrahman Şahin, Oğuzhan Öztürk, Zuhal Çalışkan, Süleyman Sayar, Hamdi Levent Doğanay, Kamil Özdil, Bedia Çakmakoğlu. Investigations of the EGF and its receptor EGFR gene variants in ulcerative colitis. XV. Euroasıan Congress of Gastroenterology and Surgery Congress Presentation 3rd Prize.

1. Kahraman R, Calhan T, Sahin A, Ozdil K, Caliskan Z, Bireller ES, Cakmakoglu B. Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease? Ther Clin Risk Manag. 2017 Sep 30;13:1295-1301.
2. Kahraman R, İplik E, Calhan T, Sahin A, Cakmakoglu B. Assessment of the role of EGF +61A/G and EGFR R497K polymorphism in patients with inflammatory bowel disease: A case-control study. Archives of Clinical and Experimental Medicine. 2018; 3(2): 83-79. 
3. Resul Kahraman, Abdurrahman Şahin, Oğuzhan Öztürk, Turan Calhan, Süleyman Sayar, Evren Kanat, Levent Doğanay, Kamil Özdil Effects of long-term tenofovir disoproxil fumarate and entecavir treatment on bone mineral density in patients with chronic Hepatitis B Turk J Gastroenterol 2019; 1: –
4. Kelleci UA, Calhan T, Sahin A, Aydin-Ozemir Z, Kahraman R, Ozdil K, Sokmen HM,Yalcin AD. Electroencephalography Findings in Crohn’s Disease. Clin EEG Neurosci. 2018
5. Katrinli S, Nilay Karatas Erkut G, Ozdil K, Yilmaz Enc F, Ozturk O, Kahraman R, Tuncer I, Dinler Doganay G, Doganay L. HLA DPB1 15:01 Allele Predicts Spontaneus Hepatitis B Surface Antigen Seroconversion. Acta Gastroenterol Belg. 2017 Jul-Sep;80(3):351-355.
6. Caliskan Z, Keles N, Gokturk HS, Ozdil K, Aksu F, Ozturk O, Kahraman R, Kostek O, Tekin AS, Ozgur GT, Caliskan M. Is activation in inflammatory bowel diseases associated with further impairment of coronary microcirculation? Int J Cardiol. 2016 Aug 8;223:176-181. doi: 10.1016/j.ijcard.2016.08.141. [Epub ahead of print] PMID:27541650
7. Caliskan Z, Keles N, Kahraman R, Özdil K, Karagoz V, Aksu F, Aciksari G, Yilmaz Y, Kul S, Caliskan M. Imparied retrobulbar blood flow and increased carotid IMT in patients with Crohn’s disease. Int J Cardiovasc Imaging. 2016 Aug 13. [Epub ahead of print] PMID:27522671
8. Kamil O.,Kahraman R, Abdullah S.,Turan C.,Erdem H.Gozden,Umit A.,Burak E.,Mehmet H.Sokmen,Erratum to:Bone density in proton pump inhibitors users:a prospective study.DOI 10.1007/s00296-016-3554-8
9. Ulker Anadol Kelleci, Turan Calhan, Abdurrahman Sahin, Resul Kahraman, Kamil Ozdil, H. Mehmet Sokman, Destina Yalcın. The Prevalence of Headache in Crohn’s Disease : single Center Experience. Gastroenterology Research and Practice 2015. Volume 2016. Article ID:6474651, 6 pages
10. Abdurrahman sahin, Gamze Geyik, Turan Calhan, Resul Kahraman, Aysenur Ihvan, Kamil Ozdil, Hacı Mehmet Sokmen. Amebiasis Masquerading Colonic Lymphoma in an Intestinal Intussusception Patient. J Med Cases.2014,5(8):441-444
11. Calhan T, Sahin A, Kahraman R, Altunoz ME, Ozbakır F, Ozdil K, Sokmen HM. Antineutrophil cytoplasmic antibody frequency in chronic hepatitis B patients.Dis Markers. 2014;2014:982150. doi: 10.1155/2014/982150. Epub 2014 Aug 5.
12. Abdurrahman Sahin, Turan Calhan, Mustafa Cengiz, Resul Kahraman, Kubra Aydin, Kamil Ozdil, May Korachi, and H. Mehmet Sokmen. Serum Interleukin 17 Levels in Patients with Crohn’s Disease: Real Life Data. Disease Markers Volume 2014 (2014), Article ID 690853, 6 pages.
13. Ozdil K, Kahraman R, Sahin A, Calhan T, Gozden EH, Akyuz U, Erer B, Sokmen MH. Bone density in proton pump inhibitors users: a prospective study. Rheumatol Int. 2013 Mar 2. [Epub ahead of print] PMID:23455632[PubMed – as supplied by Publisher
14. Calhan T, Kahraman R, Sahin A, Senates E, Doganay HL, Kanat E, Ozdil K, Sokmen HM. Efficacy of Two Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori: A Pilot Study. Helicobacter. 2013 Apr 21. doi: 10.1111/hel.12056. [Epub ahead of print] PMID:23601026
15. Ozdil K, Kahraman R, Sahin A, Akyuz U, Topal CS, Sokmen HM. The frequency of microscopic and focal active colitis in patients with irritable bowel syndrome. BMC Gastroenterology. 2011.
16. Sokmen HM, Ozdil K, Calhan T, Sahin A, Senates E, Kahraman R, Nigdelioglu A, Zemheri E. Situs inversus totalis and secondary biliary cirrhosis: a case report. Comp Hepatol. 2011 Aug 3;10(1):5.
17. Ozdil K, Calhan T, Sahin A, Kahraman R, Levofloxacin based sequential and triple therapy compared with standart plus probiotic combination for Helicobacter pylori eradication. Manuscript number 11075. Hepato-gastroenterology. 2011 Jul-Aug;58(109):1148-52. doi: 10.5754/hge11075
18. Ozdil K, Sahin A, Kahraman R, Yuzbasioglu B, Demirdag H, Calhan T, Yilmaz MS, Sokmen HM. Current prevalence of intestinal metaplasia and Helicobacter pylori infection in dyspeptic adult patients from Turkey. Hepatogastroenterology. 2010 Nov-Dec;57(104):1563-6.
19. Seyma Katrinli1, G. Nilay Karatas Erkut, Kamil Ozdil, Feruze Yilmaz Enc, Oguzhan Ozturk, Resul Kahraman, Ilyas Tuncer, Gizem Dinler Doganay, Levent Doganay HLA DPB1 15:01 Allele Predicts Spontaneus Hepatitis B Surface Antigen Seroconversion Acta Gastro-enterologica Belgica,80 (3), September,2017
20. Kamil Ozdil, Zuhal Caliskan,Nursen Keles,Oguzhan Ozturk,Ahmet Selami Tekin, Resul Kahraman,Levent Doganay,Kenan Demircioglu,Yusuf Yilmaz, Mustafa Caliskan Echocardiographic epicardial fat thickness measurement: A new screening test for subclinic atherosclerosis in patients with inflammatory bowel diseases North Clin Istanb 2017;4(1):4–12 doi: 10.14744/nci.2017.74508
21. Kamil O.,Resul K.,Abdullah S.,Turan C.,Erdem H.Gozden,Umit A.,Burak E.,Mehmet H.Sokmen,Erratum to:Bone density in proton pump inhibitors users:a prospective study.DOI 10.1007/s00296-016-3554-8
22. Guntas G, Sahin A, Duran S, Kahraman R, Duran I, Sonmez C, Calhan T, Sokmen HM. Evaluation of Ischemia-Modified Albumin in Patients with Inflammatory Bowel Disease. Clin Lab. 2017 Feb 1;63(2):341-347.
23. Dinçol G, Kahraman R. Cryptococcus neoformans meningitis in a patient with hairy cell leukemia. Am J Hematol. 2006 May;81(5):387.
24. Dinçol G, Doğan O, Küçükkaya RD, Gül E, Kahraman R, Ağan M. Hairy cell leukaemia presenting with ascites, pleural effusion and increased CA 125 serum level. Neth J Med. 2008 Jan;66(1):23-6
25. Atypical Presentation of Celiac Disease in an Elderly Adult: Celiac Crisis. Yilmaz B, Aksoy EK, Kahraman R, Yaprak M, Sıkgenc M, Dayan R, Eren I, Efe C. J Am Geriatr Soc. 2015 Aug;63(8):1712-4. doi: 10.1111/jgs.13583.
26. A Lethal Complication of Endoscopic Therapy: Duodenal Intramural Hematoma Turan Calhan, Abdurrahman Sahin, Resul Kahraman, Barış Soydaş, Ali Tosun, and Egemen Cebeci Endoscopy 2014; 46(S 01): E302-E303
27. Atypical placement of the pylorus: a rare congenital abnormality Turan Calhan, Abdurrahman Sahin, Resul Kahraman, Aziz Batu
28. Sayar S, Kurbuz K, Kahraman R, et al. A practical marker to determining acute severe ulcerative colitis: CRP/albumin ratio. North Clin Istanb. 2019;7(1):49‐55. Published 2019 Nov 25. doi:10.14744/nci.2018.78800
29. Caliskan, Z, Telci Caklili, O, Kahraman, R, et al. Does celiac disease impair coronary microvascular circulation: Coronary flow velocity reserve of patients with celiac disease. Echocardiography. 2020; 37: 34– 40
30. Sayar, S., Kürbüz, K., Kahraman, R., Öztürk, O., Çalışkan, Z., Doğanay, H. L., Özdil, K. (2020). Risk of hepatitis B reactivation during anti-TNF therapy; evaluation of patients with past hepatitis B infection. The Turkish journal of gastroenterology : 31(7), 522–528.
31. Kilic ET, Sayar S, Kahraman R, Ozdil K. The effects of obesity on sedation-related outcomes of advanced endoscopic procedures. North Clin Istanb. 2019 Oct 24;6(4):321-326. doi: 10.14744/nci.2019.93763. PMID: 31909375; PMCID: PMC6936949.
32. Ebru TK, Resul K. Comparison of ketamine-propofol mixture (ketofol) and midazolam-meperidine in endoscopic retrograde cholangiopancretography (ERCP) for oldest old patients. Ther Clin Risk Manag. 2019 Jun 18;15:755-763. doi: 10.2147/TCRM.S201441. PMID: 31417263; PMCID: PMC6592063.
33. Caliskan Z, Demircioglu K, Sayar S, Kahraman R, Caklili O, Ozcan FB, Kostek O, Baycan OF, Doganay HL, Caliskan M. Lipid profile, atherogenic indices, and their relationship with epicardial fat thickness and carotid intima-media thickness in celiac disease. North Clin Istanb. 2019 Sep 2;6(3):242-247. doi: 10.14744/nci.2019.54936. PMID: 31650110; PMCID: PMC6790920.
34. Caliskan Z, Tatlisu MA, Kahraman R, Gokturk S, Sayar S, Kostek O, Kul S, Baycan OF, Ozcan FG, Caliskan M. The Impact of Prognostic Nutritional Index on Coronary Flow Reserve in Patients with Inflammatory Bowel Disease. Medeni Med J. 2019;34(3):271-277. doi: 10.5222/MMJ.2019.47108. Epub 2019 Sep 27
35. Tarikci Kilic E, Kahraman R, Ozdil K. Evaluation of Safety and Outcomes of Endoscopic Retrograde Cholangiopancreatography in 1337 Patients at a Single Center. Medeni Med J. 2019;34(3):290-296. doi: 10.5222/MMJ.2019.58265. Epub 2019 Sep 27. PMID: 32821451; PMCID: PMC7433733.
36. Demir A, Kahraman R, Candan G, Ergen A. The role of FAS gene variants in inflammatory bowel disease. Turk J Gastroenterol. 2020 May;31(5):356-361. doi: 10.5152/tjg.2020.19436. PMID: 32519954; PMCID: PMC7289171.
37. Candan G, Kahraman R, Ergen A. Irak-4 rs4251481 gene variant: as a risk factor on inflammatory bowel disease. Turk J Med Sci. 2019 Apr 18;49(2):478-482. doi: 10.3906/sag-1807-279. PMID: 30997787; PMCID: PMC7018251.
38. Kalkanli Tas, Sevgia; Kirkik, Duygub; Tanoglu, Alpaslanc; Kahraman, Resuld; Ozturk, Kubrab; Esen, Muhammed Fevzie; Coskunpinar, Mehmet Enderb; Cagiltay, Eylemf Polymorphisms in Toll-like receptors 1, 2, 5, and 10 are associated with predisposition to Helicobacter pylori infection, European Journal of Gastroenterology & Hepatology: September 2020 – Volume 32 Issue 9 – p 1141-1146 doi: 10.1097/MEG.0000000000001797
39. Sayar, Suleymana; Ayranci, Gülçiçekb; Kürbüz, Kemala; Ak, Çağataya; Tarikçi Kiliç, Ebruc; Kahraman, Resula; Atalay, Ronia; Öztürk, Oğuzhana; Çalişkan, Zuhala; Adali, Gupsea; Doganay, Leventa; Özdil, Kamila High frequency of gastric cancer precursor lesions in patients with gastric xanthelasma: a prospective case-control study, European Journal of Gastroenterology & Hepatology: September 2020 – Volume 32 – Issue 9 – p 1130-1134 doi: 10.1097/MEG.0000000000001795
40. Sayar S, Aykut H, Kaya Ö, Kürbüz K, Ak Ç, Gökçen P, Mutlu Bilgiç N, Adalı G, Kahraman R, Doganay L, Özdil K. Bone Mineral Density Screening and the Frequency of Osteopenia/Osteoporosis in Turkish Adult Patients With Celiac Disease. Turk J Gastroenterol. 2021 Jul;32(7):600-607. doi: 10.5152/tjg.2021.20313. PMID: 34464324.
41. Guvendir I, Zemheri IE, Altundal K, Ozdil K, Kahraman R, Tosun I. Ossified uncertain malignant potential gastric glomus tumor with tumor thrombus. Indian J Pathol Microbiol. 2021 Apr-Jun;64(2):369-37
42. Uluslararası Bilimsel Toplantılarda Sunulan ve Bildiri Kitabında (Proceedings) Basılan Bildiriler
    
    
43. Ozdil K, Calhan T, Sahin A, Kahraman R, Levofloxacin based sequential and triple therapy compared with standart plus probiotic combination for Helicobacter pylori eradication.(National Scholar Award). OP 262, 2011 UEGW Stockholm. SÖZLÜ BİLDİRİ
44. Ozdil K1, Kahraman R1, Sahin A1, Calhan T1, Nigdelioglu A1, Gozden HE2, Akyuz U3, Erer B4, Senates E5, Sokmen HM1 . A prospective evaluation of bone density in patients using proton pump inhibitors for gastroesophageal reflux disease. OP 153, UEGW 2011, Stockholm.
45. Calhan T, Kahraman R, Sahin A, Senates E, Doganay HL, Kanat E, Ozdil K, Sokmen HM. Efficacy of Two Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori: A Pilot Study. UEGW Berlin 2013
46. Resul Kahraman, Sinem Bireller, Turan Çalhan, Abdurrahman Şahin, Oğuzhan Öztürk, Zuhal Çalışkan, Süleyman Sayar, Hamdi Levent Doğanay, Kamil Özdil, Bedia Çakmakoğlu. Investigations of the EGF and its receptor EGFR gene variants in ulcerative colitis. XV. Euroasıan Congress of Gastroenterology and Surgery 27 apr-01 May 2016, Antalya P:89.
47. Hepatitis b reactivation rate in patients using anti tnf theraphy: Evaluation of patients not received anti viral prophylaxis Süleyman Sayar, Kemal Kürbüz, Çağatay Ak, Nermin Mutlu Bilgiç, Resul Kahraman, Hakan Demirdağ, Roni Atalay, Zuhal Çalışkan, Oğuzhan Öztürk, Hamdi Levent Doğanay, Kamil Özdil AASLD – TASL CONNECT REGIONAL MEETING March 15-16, 2019 – İstanbul, Turkey P-018
48. Evaluation of diagnostic performance simple non-invasıve fibrosis markers in patients with chronic hepatitis B Süleyman Sayar, Roni Atalay, Şuheda Çakmak , Gülçiçek Ayrancı, Kemal Kürbüz , Resul Kahraman , Zuhal Çalışkan, Hakan Demirdağ, Oğuzhan Öztürk 1 , Kamil Özdil 1 , Hamdi Levent Doğanay AASLD – TASL CONNECT REGIONAL MEETING March 15-16, 2019 – İstanbul, Turkey PP-00